News
GlobalData on MSN9d
FDA approves label updates for BMS’ CAR T cell therapiesBristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates ...
Exelixis (NasdaqGS:EXEL) recently announced positive topline results from the STELLAR-303 Phase 3 trial, highlighting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback